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1. Introduction 
Embryonic development and later rejuvenation of adult tissues are regulated by a 
population of stem cells (SCs) that, by undergoing self-renewal, maintain their own pool 
and, by giving rise to differentiated progenitors, replace cells used up during life (Ratajczak 
et al., 2007). Thus, SCs are guardians of tissue/organ integrity and regulate the life span of 
an adult organism. The most important SCs, from a regenerative potential point of view, are 
pluripotent stem cells (PSCs). According to their definition, such cells must meet certain in 
vitro and in vivo criteria. PSCs must: i) give rise to cells from all three germ layers; ii) 
complete blastocyst development; and iii) form teratomas after inoculation into 
experimental animals.  
The SC compartment shows a high degree of hierarchy (Hayashi & Surani, 2009). In 
embryonic development, the most primitive stem cells are the fertilized oocyte (zygote) and 
the first blastomers in the morula. These cells are called totipotent, possessing the ability to 
give rise to both embryo and placenta. The developing morula gives rise to the blastocyst, 
where PSCs are found in the inner cell mass (ICM).  These cells may give rise to all three 
germ layers of the developing embryo; however, they have lost the ability to differentiate 
into placenta. The PSCs at this stage can be expanded ex vivo as immortalized embryonic 
stem cell (ESC) lines (Evans & Kaufman, 1981).  
After implantation of the blastocyst, PSCs from the blastocyst ICM give rise to pluripotent 
epiblast stem cells (EpiSCs) that will form  the entire embryo proper (Brons et al., 2007; Tesar 
et al., 2007). During the gastrulation process, cell lineage determination programs are  
initiated and EpiSCs respond to the signals from surrounding extra-embryonic tissues, 
which leads to their differentiation into several types of tissue-committed stem cells (TCSCs) 
(Ratajczak et al., 2007). TCSCs are monopotent (unipotent), which means they are restricted 
in their differentiation potential to cells for one tissue only (e.g., epidermis, intestinal 
epithelium, liver, skeletal muscles, or lympho-hematopoietic). TCSCs terminate expression 
of pluripotent genes and, at the same time, turn on lineage-specific molecular programs.  
The first population of SCs, which at around embryonic day 7.25 (E7.25) become specified in 
the proximal epiblast, are primordial germ cells (PGCs), and alkaline phosphatase (AP)-
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positive PGCs grow into extra-embryonic mesoderm at the base of the allantois as an 
appendage arising from around the posterior primitive streak (Surani et al., 2007). These 
cells transcribe pluripotency-related genes, such as Oct-4, Nanog, and Sox2, and are the only 
population of SCs that maintains expression of these genes during gastrulation. When PGCs 
are cultured over murine embryonic fibroblasts and exposed ex vivo to three growth factors 
(kit ligand, leukemia inhibitory factor, and basic fibroblast growth factor), they continue to 
proliferate and form large colonies of embryonic germ cells (EGCs), which, like ESCs, can be 
expanded indefinitely (Matsui et al., 1992). At around E12.5, PGCs arrive at the genital 
ridges, lose their markers of pluripotency, and initiate their commitment to becoming 
gametes (oocytes and sperm).  
As mentioned above, SCs show a developmental hierarchy (Hayashi & Surani, 2009), and 
PSCs that emerge during embryogenesis give rise to more differentiated SC populations 
with the ability to self renew, but with a more limited ability for multilineage differentiation 
(Surani et al., 2007). Evidence is accumulating that differentiation potential is regulated by 
epigenetic reprogramming (Surani et al., 2007). PSCs from the ICM show global DNA 
demethylation, which results in i) activation of the X chromosome, ii) expression of germ-
line, lineage-characteristic genes (e.g Stella, Mvh, Dazl, and Sycp3), and iii) expression of 
repetitive sequence families (e.g. LINE1, SINE, and IAP). After implantation of the blastocyst 
in the uterus, ICM-derived PSCs give rise to EpiSCs and again methylate  i) the X 
chromosome, ii) promoters for genes characteristic of PSCs in the ICM (Rex-1 and Stella), 
and iii) repetitive sequences (Hayashi et al., 2008). Whereas most  EpiSCs undergo further 
differentiation into TCSCs by stable repression of promoters for pluripotent-specific genes, 
some EpiSCs in the proximal epiblast (precursors of PGCs) revert to a state that resembles 
ICM PSCs by undergoing genome-wide DNA demethylation (Hayashi & Surani, 2009). This 
leads to re-activation of the X chromosome and promoters for germline-lineage genes and 
repetitive sequences.  
Unlike differentiated somatic cells, PSCs commonly express the pluripotency core 
transcription factors (TFs) such as Oct-4, Nanog, and Sox2 (Kim et al., 2008). These TFs form 
the pluripotency core circuitry by reinforcing the expression of genes involved in keeping 
PSCs in an undifferentiated state and, at the same time, repressing their differentiation. The 
biological significance of these core TFs has been experimentally proven by the generation of 
inducible pluripotent stem cells (iPSCs), in which fully differentiated somatic cells can be 
reprogrammed into ESC-like stem cells after transduction by so-called Yamanaka factors 
(Oct-4, Sox2, Klf4, and cMyc) (Takahashi & Yamanaka, 2006; Wernig et al., 2007).  
Another hallmark of pluripotency is the presence of transcriptionally active chromatin 
structures at the promoters of core TFs due to methylation and histone modifications of 
promoter DNA (Cedar & Bergman, 2009). Thus, promoters for core TFs in PSCs are de-
methylated and highly enriched for histone codes associated with active transcription, such 
as acetylated histones and trimethylation on lysine 4 of histone 3 (H3K4me3). In addition to 
the expression of pluripotency core TFs, undifferentiated PSCs also exhibit specific 
epigenetic marks called bivalent domains (BDs) (Azuara et al., 2006; Boyer et al., 2006; Lee et 
al., 2006; Stock et al., 2007).  In BDs, the transcriptionally active H3K4me3 code coexists with 
repressive histone codes, such as trimethylated lysine 27 in histone 3 (H3K27me3). The BDs 
are mainly detected in the promoter regions of homeodomain-containing developmental 
master TFs, such as Dlx-, Irx-, Lhx-, Pou-, Pax-, and Six-family proteins. Due to the 
overwhelming effect of the transcription-repressive activity of H3K27me3, the transcription 
of BD-controlled  genes is transiently repressed to prevent premature differentiation. 
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However, in response to developmental stimuli, BDs in promoters of these genes are 
switched into the monovalent type that promotes transcription. Therefore, both positive 
(expression of Oct-4-Nanog-Sox2) and negative (repression of differentiation-inducing TFs 
by bivalent domains) mechanisms are indispensable for controlling the pluripotent state of 
PSCs. 
As mentioned before, PSCs are detected only during very early embryonic development and 
they disappear after differentiation into TCSCs and germline cells (Niwa, 2007). However, 
recent evidence has accumulated demonstrating that PSCs may reside in adult tissues and 
are able to differentiate into TCSCs (Ratajczak et al., 2007). These cells have been variously 
described in the literature as i) multipotent adult progenitor cells (MAPCs), ii) marrow-
isolated adult multilineage-inducible (MIAMI) cells, iii) multipotent adult (MA) SCs, or iv) 
OmniCytes (Beltrami et al., 2007; D'Ippolito et al., 2004; Jiang et al., 2002; Pochampally et al., 
2004). Thus, the physical presence of PSCs in adult tissues may better explain stem cell 
plasticity, according to which TCSCs are purportedly plastic and can trans-dedifferentiate 
into SCs for other tissues.  
However, several questions remain to be addressed regarding these rare PSCs. First, the 
developmental origin of these cells is unresolved. As shown in Figure 1, PSCs during 
embryogenesis/gastrulation may become eliminated after giving rise to TCSCs, or 
conversely, they may survive among TCSCs and serve as a back-up/reserve source for these 
cells. Thus, it is important to elucidate whether PSCs found in adult tissue cells are 
functional under steady-state conditions or are merely remnants from developmental 
embryogenesis that reside in a dormant state in adult tissues. Second, is the question of 
  
 
Fig. 1. Developmental specification of PSCs into TCSCs. Scenario I: During 
embryogenesis/gastrulation, PSCs  are eliminated after giving rise to TCSCs and PGCs. 
Scenario II: PSCs survive and serve as a back-up/reserve source of TCSCs.  
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whether the dormant state of these cells is regulated by cell-intrinsic epigenetic 
reprogramming similar to other PSCsduring embryogenesis. Finally, there is the question of 
whether their dormant state is influenced by microenvironmental cues, such as their  (i) 
location in non-physiological niches, (ii) exposure to inhibitors, or  (iii) deprivation of 
appropriate stimulatory signals. The answer to these questions could be key to successful 
application of these adult-tissue-derived PSCs in the clinical setting. In this chapter, we will 
discuss these issues in more detail. 
2. Very small embryonic-like stem cells (VSELs) residing in adult tissues 
Recently, our group purified a population of very small embryonic-like stem cells (VSELs) 
from BM by employing a multiparameter fluorescence-activated cell sorter (FACS) (Kucia et 
al., 2006b). These rare Sca-1+Lin–CD45– cells reside in several adult murine organs (e.g., 
brain, liver, skeletal muscles, heart, and kidney) (Zuba-Surma et al., 2008) and recently were 
detected also in human umbilical cord-blood and mobilized peripheral-blood (Kucia et al., 
2006a; Paczkowska et al., 2009; Wojakowski et al., 2009). VSELs are very small in size (~3–6 
m) and express pluripotent markers, such as Oct-4, Nanog, Rex-1, and SSEA-1 (Kucia et al., 
2006b). They are morphologically, similarly to ESCs, possessing large nuclei containing 
unorganized chromatin (euchromatin) and exhibiting a significantly higher 
nuclear/cytoplasm (N/C) ratio and a lower cytoplasmic area than hematopoietic stem cells 
(HSCs). The true expression of Oct-4 and Nanog in BM-derived murine VSELs was recently 
confirmed by demonstrating transcriptionally active chromatin structures for both Oct-4 and 
Nanog promoters (Shin et al., 2009).  If cultured under a C2C12 myoblast feeder layer, 
freshly isolated VSELS form spheres corresponding to embryoid bodies (EBs). These VSEL-
derived spheres (VSEL-DSs) contain primitive SCs that, after replating into tissue-specific 
differentiation media, are induced to differentiate into cells from all three germ layers (Kucia 
et al., 2008a). From experiments with mouse models, it has been proposed that VSELs are 
mobilized into peripheral blood in response to injury and circulate to the organ of injury in 
an attempt to enrich and regenerate damaged tissues (e.g., following heart infarct or stroke) 
(Kucia et al., 2008b; Paczkowska et al., 2009; Wojakowski et al., 2009). This physiological 
mechanism probably plays a significant role in the regeneration of some small tissue and 
organ injuries; however, further studies are needed to demonstrate that these cells do in fact 
home to the damaged organs. 
3. Molecular signature of VSELs residing in BM 
To investigate the relationship between VSELs and embryonic PSCs (e.g. embryonic stem 
cells [ESCs], epiblast stem cells [EpiSCs], primordial germ cells [PGCs], and embryonic germ 
cells [EGs]), we employed several molecular strategies to evaluate VSEL molecular 
signatures (Figure 2). Highly purified Sca-1+Lin–CD45– VSELs from murine BM were 
evaluated for i) expression of pluripotent genes, epiblast/germ line markers, and 
developmentally crucial imprinted genes; ii) the presence of BDs; and iii) reactivation of the 
X chromosome in female VSELs.  
3.1 VSELs express PSC genes 
PSCs express the essential pluripotency TF Oct-4. The importance of this TF is well-
established by the fact that transduction with Oct-4 is obligatory in several protocols for 
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generating iPSCs. We found that VSELs express Oct-4 at both the mRNA and protein level 
(Kucia et al., 2006a). However, recently some doubts have been raised about whether cells 
isolated from adult tissues express these embryonic genes, and it has been suggested that 
positive PCR data showing Oct-4 expression may be due to amplification of Oct-4 
pseudogenes (Lengner et al., 2007; Liedtke et al., 2007). Thus, to prove true expression of the 
Oct-4 gene in VSELs, we investigated the epigenetic state of the Oct-4 promoter. Our DNA 
methylation studies of the Oct-4 promoter using bisulfite sequencing revealed that it is 
hypomethylated in highly purified Sca-1+Lin–CD45– VSELs, similarly to cells isolated from 
ESC-derived EBs (28% and 13.2%, respectively) (Shin et al., 2009). Next, to evaluate the state 
of histone codes for the Oct-4 promoter, we performed the chromatin-immunoprecipitation 
(ChIP) assay to verify its association with acetylated histone 3 (H3Ac) and dimethylated 
lysine 9 of histone 3 (H3K9me2), the molecular marks for open- and closed-type chromatin, 
respectively. By employing the carrier-ChIP assay (using the human hematopoietic cell-line 
THP-1 as carrier) we found that Oct-4 promoter chromatin is associated with H3Ac and its 
association with H3K9me2 is relatively low (Shin et al., 2009). We also evaluated the 
epigenetic state of another core TF,  Nanog, and observed that its promoter has a higher level 
of methylation in VSELs (50%). However, in quantitative ChIP experiments performed in 
parallel,  it was confirmed that the H3Ac/H3K9me2 ratio favors transcription and supports 
its active state (Shin et al., 2009). Based on these results, we conclude that VSELs truly 
express Oct-4 and Nanog. Of note, we also reported that VSELs express several  
other markers of PSCs, such as SSEA-1 antigen, as well as Sox2 and Klf4 TFs (Shin et al., 
2010b). 
3.2 Expression of epiblast markers 
As a result of the epigenetic reprogramming that occurs during implantation of the 
blastocyst, EpiSCs exhibit transcription profiles different from ESCs. For example, the 
expression of Nanog, Sox2, and Stella is reduced in EpiSCs through DNA methylation of 
their promoters (Surani et al., 2007). In functional assays, EpiSCs, unlike ESCs, show a 
highly restricted capacity to complement blastocyst development (Brons et al., 2007; Tesar et 
al., 2007). However, pluripotent EpiSCs may differentiate in vivo into TCSCs, which during 
embryogenesis orchestrate organogenesis and later in adult life are involved in rejuvenation 
of tissues and organs. Like EpiSCs, highly purified BM-derived Oct-4+ VSELs do not 
complement blastocyst development and therefore cannot enable in vitro differentiation into 
cells from all three germ layers. Therefore, we have hypothesized that VSELs may be 
epiblast-derived precursors of TCSCs (Ratajczak et al., 2010). To investigate the similarity 
between VSELs and EpiSCs, we examined  the expression of genes that are characteristic of 
EpiSCs (Gbx2, Fgf5, and Nodal) and ESCs from the blastocyst ICM (Rex-1) in adult BM-
derived VSELs.  It is known that Gbx2, Fgf5, and Nodal are upregulated in EpiSCs, but are 
expressed at lower levels in ESCs isolated from the ICM (Hayashi et al., 2008). In contrast, 
the level of Rex-1 transcripts is highly expressed in ICM cells. We found that VSELs highly 
express Gbx2, Fgf5, and Nodal, but express the Rex-1 transcript at a low level compared to the 
established murine ESC cell line, ESC-D3. This suggests that VSELs are more differentiated 
than ICM-derived ESCs and share several markers with more differentiated EpiSCs (Shin et 
al., 2010b). 
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Fig. 2. Epigenetic modification of VSELs during embryogenesis and aging. Epigenetic 
modifications control the differentiation potential of SCs during embryogenesis and aging. 
The DNA methylation processes during development of ICM-derived epiblast SCs specify 
them to TCSCs. However, at the beginning of gastrulation, the proximal epiblast-specified 
PGCs can reset their epigenetic profile to one that characterizes ICM-derived PSCs. 
Subsequently, during PGC migration to the genital ridges, global DNA demethylation leads 
to the erasure of genomic imprints. Consistent with the hypothesis that VSELs originate 
from an epiblast-derived PGC population, they show a PGC-like epigenetic profile, 
including partial DNA demethylation of several pluripotency, germ-line, and genomic 
imprints. These epigenetic profiles of developing VSELs are retained after their deposition 
into adult tissues. This parent-specific reprogramming of the genomic imprinting of VSELs 
deposited in adult tissues (e.g., BM) functions as i)  a “lock-in mechanism” to prevent their 
inappropriate proliferation and ii) a mechanism to restrict their sensitivity to Ins/Igf 
signaling. During the aging process, while residing in adult tissues, VSELs exposed  to 
oxidative stress or chronic Ins/Igf signaling de-repress locked-in genomic imprints and 
progressively methylate DNA in the Oct-4 promoter (Ratajczak et al 2011a). As a result of 
these epigenetic changes, the total number and pluripotency of VSELs decreases with age 
(Ratajczak et al. 2008), which leads to impaired tissue regeneration and rejuvenation. 
3.3 Expression of germline markers 
During gastrulation, EpiSCs lose expression of core pluripotency TFs. On the other hand, 
during specification of proximal epiblast EpiSCs into PGCs, the expression of these early 
embryonic genes is re-activated by resetting epigenetic programs in these cells (Hayashi & 
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Surani, 2009). Thus, PGCs reset epigenetic marks to an ICM-like state, which results in re-
activation of pluripotency and germline-related genes (Hayashi & Surani, 2009). The 
specification of PGCs is initiated at E7.25 by expression of germline master regulators, such 
as Fragilis, Blimp1, and Stella, in response to signals from extra-embryonic tissues (Surani et 
al., 2007). At this time, around 40 proximal epiblast-derived PGCs are detected. At E8.5, 
PGCs enter back into the embryo proper through the primitive streak and start migration 
through the hindgut endoderm and mesentry to the aorta-gonads-mesonephros (AGM) 
region, and at around E11.5 they reach the genital ridge in which PGCs differentiate into 
monopotent gametes (sperm and egg). Our data indicate some relationship between VSELs 
and PGCs (Shin et al., 2010b). Accordingly, VSELs are reported to highly express genes that 
are involved in germ-line specification of the epiblast (e.g., Stella, Prdm14, Fragilis, Blimp1, 
Nanos3, and Dnd1). The expression of Stella, Blimp1, and Mvh has been confirmed at the 
protein level by immunostaining. Furthermore, the Stella promoter in VSELs is partially 
demethylated and displays transcriptionally active histone modifications (H3Ac and 
H3K4me3) and is less enriched for transcriptionally repressive histone marks (H3K9me2 
and H3K27me3) (Shin et al., 2010b). It can be concluded that VSELs express several 
germline-specific genes and display a Stella promoter chromatin structure that is 
characteristics of germline specification. VSELs also highly express Dppa2, Dppa4, and Mvh, 
which characterize late migratory PGCs; however, they do not express Sycp3, Dazl, and 
LINE1 genes that are expressed in post-migratory PGCs (Maatouk et al., 2006; Maldonado-
Saldivia et al., 2007). Thus, our results in toto support the conclusion that VSELs deposited 
into murine BM show some similarities in gene expression and epigenetic signatures to 
epiblast-derived migratory PGCs (at ~E10.5–E11.5). 
3.4 VSELs are marked by BDs 
As mentioned above, in undifferentiated ESCs, most of the homeodomain-containing 
developmental TFs are repressed by BDs (Bernstein et al., 2006), which are chromatin 
structures in which transcriptionally opposite histone codes physically co-exist in the same 
promoter. In undifferentiated ESCs, BD epigenetic codes at the promoters of these TFs are 
temporarily repressed, preventing their premature differentiation. During differentiation, 
the transient repressive epigenetic marks in these TFs become monovalent and thereafter 
activate or repress expression of the appropriate TFs. Our preliminary data indicate that 
murine VSELs display BDs in the promoters of several homeodomain-containing 
developmental TFs (Sox21, Nkx2.2, Dlx1, Lbx1h, Hlxb9, Pax5, and HoxA3). The presence of 
transcriptionally active histone codes, such as H3K4me3, physically coexisting with 
repressive histone codes, such as H3K27me3, was confirmed by employing the carrier-ChIP 
assay (submitted for publication). 
3.5 VSELs from female mice partially activate an X chromosome 
The process of X-chromosome inactivation is mediated by expression of the large noncoding 
RNA Xist, which is transcribed on the inactivated X chromosome. Coating of the X 
chromosome to be inactivated by spreading of Xist RNA induces the silenced chromatin 
structure (Payer & Lee, 2008). As already mentioned above, it is well known that female 
PSCs (e.g., murine and human ESCs isolated from the blastocyst ICM, as well as PGCs) 
reactivate  the X chromosome that was inactivated after fertilization, and, as a result, female 
PSCs display two equivalently activated X chromosomes (Surani et al., 2007). Our initial 
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studies in murine female VSELs show that these cells partially reactivate the inactivated X 
chromosome. As mentioned above, female murine VSELs partially hypermethylate the Xist 
promoter (~80%), unlike somatic cells which show 50% DNA methylation. This result 
strongly suggests that murine VSELs, like ESCs and PGCs, can undergo the process of X 
chromosome reactivation (submitted for publication).  
4. Developmental origin of VSELs 
Taking into consideration all the molecular signatures characteristic of  VSELs, we propose 
that VSELs are epiblast-derived PSCs deposited early during embryogenesis in developing 
organs as a potential reserve pool of precursors for TCSCs. Thus, VSELs have an important 
role in tissue rejuvenation and regeneration (Shin et al., 2010a). Because of the gene 
expression profile and epigenetic state of the core TFs, expression of epiblast and germline 
genes suggests that VSELs deposited in adult BM originate from migratory PGCs that have 
gone astray from the “orthodox” migration route.  
From the second trimester on, VSELs are easily found as a Sca-1+Lin–CD45– population in 
murine fetal liver, which  is the main embryonic hematopoietic tissue. VSELs that emerge in 
fetal liver (FL-VSELs) follow the developmental route of hematopoietic stem cells (HSCs)  and 
subsequently colonize BM together with HSCs (Zuba-Surma et al., 2009).  FL-VSELs and their 
BM-derived counterparts express a similar pattern of pluripotent and epiblast/germline genes 
at the mRNA and protein levels. Accordingly, the promoters for Oct-4, Nanog, and Stella show 
significant DNA demethylation and enriched histone modifications for an open, 
transcriptionally active structure in these promoters (Shin et al., 2010a).  
Mounting evidence also indicates that PGCs could be related to HSCs, another population 
of highly migratory SCs (De Miguel et al., 2009). In support of this notion, the first primitive 
HSCs appear in the extra-embryonic tissues in yolk sac blood islands at the time when 
proximal epiblast-specified PGCs enter the extra-embryonic mesoderm (Mikkola & Orkin, 
2006). In addition, the appearance of definitive HSCs in the AGM region of the embryo 
proper coincides with migration of PGCs to the genital ridges through the AGM (De Miguel 
et al., 2009). Furthermore, PGCs isolated from murine embryos have been proven to be able 
to grow HSC colonies while, on the other hand, robust hematopoietic differentiation has 
been observed in some classical germline tumors (Kritzenberger & Wrobel, 2004; Ohtaka et 
al., 1999; Rich, 1995; Saito et al., 1998; Woodruff et al., 1995). All this suggests developmental 
overlap between PGCs and HSCs. 
On the other hand, VSELs share several characteristics with both PGCs and HSCs.  In 
particular, VSELS i) share several  BM- and FL-derived markers characteristic of the 
epiblast/germ line (Shin et al., 2010b), ii)  follow the developmental route of HSCs (Zuba-
Surma et al., 2009), and iii), in appropriate culture conditions, can also be differentiated 
toward the hematopoietic lineage. All of this suggests that VSELs are the most primitive 
murine BM-residing population of SCs and function as precursors for long-term 
repopulating HSCs (Ratajczak et al., 2011b).  
Thus, PGCs, HSCs , and VSELs together form a unique highly migratory population of 
interrelated SCs that may be envisioned as  a kind of 4th (highly migratory) germ layer. Due 
to this unique developmental origin, VSELs show characteristic epigenetic reprogramming 
and gene expression in stemness, germline, and imprinted genes (as described below) that 
maintain their pluripotency, but also prevent inappropriate proliferation and teratoma 
formation (Shin et al., 2009). 
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5. Epigenetic changes of imprinted genes that regulate VSEL pluripotency 
Unlike ESCs, highly purified BM-derived Oct-4+ VSELs do not proliferate in vitro if cultured 
alone and do not grow teratomas in vivo. On the other hand, cells from VSEL-DSs have 
restored their proliferation potential, demonstrating that their quiescent state can be 
modulated. This suggests that VSELs are a quiescent cell population and that some 
mechanisms must exist to prevent their unleashing of proliferation and teratoma formation. 
Like VSELs, PGCs in cultures freshly isolated from embryos proliferate only for a few days 
before disappearing, either because they differentiate or die (De Felici & McLaren, 1983). 
They also neither grow teratomas nor complement blastocyst development (Surani et al., 
2007). However, when PGCs are cultured over a feeder layer supplemented by a specific  
combination of growth factors, they continue to proliferate and can be reprogrammed into 
EGCs (Shamblott et al., 1998; Turnpenny et al., 2003). Therefore, it is possible that these two 
SC populations employ a similar molecular mechanism to regulate their pluripotency and to 
prevent cell proliferation. 
The hallmark of epigenetic reprogramming during PGC development is erasure of genomic 
imprinting (Surani et al., 2007), which is an epigenetic process ensuring paternal-specific, 
mono-allelic expression of imprinted genes (Reik & Walter, 2001). Around 80 imprinted 
genes (expressed from maternal or paternal chromosomes only) have been reported in the 
mouse genome and their proper mono-allelic expression regulates totipotency and 
pluripotency of the zygote and developmentally early SCs, respectively. Furthermore, most 
imprinted genes, such as insulin-like growth factor 2 (Igf2), H19, Igf2 receptor (Igf2R), and 
p57KIP2 (also known as Cdkn1c) are directly involved in embryo development. Since the 
majority of imprinted genes exist as gene clusters enriched for CpG islands, their expression 
is coordinately regulated by the DNA methylation state of CpG-rich cis-elements known as 
differentially methylated regions (DMRs) (Delaval & Feil, 2004). The differential 
methylation state of DMRs is mediated by DNA methyltransferases (Dnmts), depending on 
the parental allele of origin. Depending on the developmental period of methylation, there 
are two types of DMRs: “primary DMRs” are differentially methylated during 
gametogenesis and “secondary DMRs” acquire allele-specific methylation after fertilization. 
So far, 15 primary DMRs have been identified in the mouse genome. Interestingly, most 
DMRs are methylated at the maternal allele and only three DMRs (at Igf2-H19, Rasgrf1, and 
Meg3 loci) are paternally methylated (Kobayashi et al., 2006). In addition to DNA 
methylation of DMRs, histone modifications also contribute to monoallelic expression of 
imprinted genes (Fournier et al., 2002; Mager et al., 2003). 
Shortly after PGC specification at E7.25, PGCs initiate epigenetic reprogramming programs, 
resulting in global DNA demethylation and changes in histone modifications (Seki et al., 
2007). As a result, epigenetic marks for genomic imprinting in both parental chromosomes 
are erased during migration into the genital ridge and new genomic imprints are established 
during differentiation into gametes in a sex-dependent manner. The erasure of genomic 
imprints could be a mechanism to protect the Oct-4-expressing germline SCs from 
uncontrolled expansion and teratoma formation. For example, while the nuclei of early 
migrating PGCs at E8.5–9.5 can be successfully used as donors for nuclear transfer, nuclei 
from post-migratory PGCs after E11.5 are incompetent to support full-term development 
(Yamazaki et al., 2003). 
Since VSELs, as discussed above, share similar molecular signatures as PGCs, we have 
proposed that VSELs, like PGCs, modify methylation of imprinted genes, which prevents 
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them from unleashing proliferation and may explain their quiescent state in adult tissues. 
Indeed, as shown in Figure 3 and Table 1, VSELs freshly isolated from murine BM erase the 
paternally methylated imprints (e.g., Igf2-H19 and Rasgrf1 loci), while they hypermethylate 
the maternally methylated ones (e.g., Igf2 receptor (Igf2R), Kcnq1-p57KIP2, and  Peg1 loci). 
Because paternally expressed imprinted genes (Igf2 and Rasgrf1) enhance embryo growth 
and maternally expressed genes (H19, p57KIP2, and Igf2R) inhibit cell proliferation (Reik & 
Walter, 2001), the unique genomic imprinting pattern observed in VSELs demonstrates 
growth-repressive imprinting in these cells. As coordinated with genomic imprinting 
reprogramming programs, VSELs highly express growth-repressive imprinted gene 
transcripts (H19, p57KIP2, and Igf2R) and downregulate growth-promoting ones (Igf2 and 
Rasgrf1), which explains the quiescent state of VSELs (Shin et al., 2009). Importantly, all the 
growth-repressive patterns of genomic imprinting are progressively recovered during the 
formation of VSEL-DSs, in which SCs proliferate and differentiate. These results suggest that 
epigenetic reprogramming of genomic imprinting should maintain the quiescence of Oct-4+ 
VSELs deposited in the adult body and protect them from premature aging and tumor 
formation. Therefore, the modulation of mechanisms controlling genomic imprinting in 
VSELs is crucial for developing more powerful strategies to unleash the regenerative 
potential of these cells for efficient employment in the clinical setting. 
6. VSELs and ageing 
Tissue regeneration depends on the  proper function of SCs, and we envision that aging can 
be partially explained by a decline in the regenerative potential of VSELs (Ratajczak et al., 
2008). In support of this notion, the number of VSELs in murine BM gradually declines with 
age, ranging from 0.052 ± 0.018% at 2 months to 0.003 ± 0.002% at  3 years of age (Kucia et 
al., 2008a). Furthermore, the frequency of VSEL-DS formation decreases with age, thus little 
VSEL-DS formation was observed in cells isolated from older mice (>2 years). Accordingly, 
VSELs from older mice (2 years) also show lower expression of pluripotency master 
regulators, such as Oct-4, Nanog, Sox2, Klf4, and cMyc, while the Oct-4 promoter in VSELs 
becomes hypermethylated with age and shows a closed chromatin structure (Ratajczak et 
al., 2011a). The age-dependent decrease of the pool size and function of VSELs in BM may 
explain the decline of regeneration potential during aging. This hypothesis has been further 
corroborated by looking for differences in the content of these cells among BM mononuclear 
cells (BMMNCs) in long- and short-lived mouse strains. The concentration of VSELs was 
much higher in the BM of long-lived (e.g., C57B6) compared to short-lived (DBA/2J) mice 
(Kucia et al., 2006b).  
We have also reported that while long-lived Laron dwarf mice, with low levels of circulating 
Igf1, have a higher number of VSELs in BM compared to normal littermates (Ratajczak et al. 
2011a), short-lived bovine-growth-hormone-expressing transgenic mice, with high 
circulating Igf1 levels, prematurely deplete this population of PSCs (submitted for 
publication). These observations suggest interesting links between high caloric uptake, 
increases in chronic insulin/insulin growth factor signaling, and premature depletion of 
VSELs.     
In support of this linkage, it is well known that changes in insulin/insulin-like growth 
factors (Ins/Igf) signaling molecules play a crucial role in aging. In particular, insulin-like 
growth factor 1 (Igf1) signaling negatively regulates the life span of animals, from worms 
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and flies to mammals (Russell & Kahn, 2007), whileIgf1 and insulin level in blood is 
regulated positively by caloric uptake (Piper & Bartke, 2008). Overall, the genomic 
imprinting reprogramming in VSELs leads to impaired Ins/Ingf signaling due to i) 
downregulation of expression of Igf2, ii) upregulation of expression of Igf2R, which serves as 
a molecular sink for Igf2, and iii) a decrease in expression of Rasgrf1, which is a small GTP 
exchange factor (GEF) for Ins/Igf signal transduction. This suggests that the epigenetic 
mechanism governing the VSEL quiescent state regulates the sensitivity to Ins/Igf signaling 
and could, if overactivated, lead to premature depletion of primitive VSELs in tissues 
(Ratajczak et al., 2011a). 
Thus, high chronic calorie uptake, followed by high plasma insulin and Igf-1 levels may, 
over time, prematurely deplete VSELs from adult organs and thus accelerate aging.  
 
 
 
Fig. 3. The unique DNA methylation pattern and expression of imprinted genes in 
VSELs. Arrows in the schematic diagram of paternally (Igf2-H19 and Rasgrf1) or maternally 
(Igf2R and Kcnq1) methylated loci indicate the transcriptional activity of the indicated gene. 
Red (up) and blue (down) arrows indicate upregulated and downregulated gene expression, 
respectively. M = maternal chromosome, P = paternal chromosome. DMR1, IG-DMR, 
KvDMR, DMR2 = DMRs for Igf2-H19, Rasgrf1, Kcnq1, and Igf2R loci, respectively. 
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Table 1 . Expression profiles of crucial imprinted genes in murine VSELs. 
The expression level of paternally (pat) or maternally (mat) expressed imprinted genes in 
murine BM-derived VSELs is indicated by red-up (up-regulated) and blue-down (down-
regulated) arrows. The effect of the indicated imprinted genes on cell proliferation is 
marked as '+' (proliferation promoting) or '–' (repressing). 
7. Regeneration potential of VSELs in vivo 
To address the most important question of whether these primitive VSELs could be 
efficiently employed in the clinic, we have tested their potential role in several in vivo tissue-
regeneration animal models. First, VSELs can be specified in vivo into mesenchymal stem 
cells (MSCs). Accordingly, in the first study by Taichman et al, VSELs isolated  from GFP+ 
mice were implanted into SCID mice, and 4 weeks later the formation of  bone-like tissues 
was observed (Taichman et al., 2010). Second, freshly isolated BM-derived VSELs from GFP+ 
mice were injected into the hearts of mice that had undergone ischemia/reperfusion injury. 
After 35 days of follow-up, VSEL-treated mice exhibited improved global and regional left 
ventricular (LV) systolic function (as determined by echocardiography) and attenuated 
myocyte hypertrophy in surviving tissue (as determined by histology and 
echocardiography) when compared with vehicle-treated controls (Zuba-Surma et al., 2010). 
Finally, we observed that VSELs, if plated over the supportive OP9 cell line, give rise to 
www.intechopen.com
Very Small Embryonic/Epiblast-Like Stem Cells (VSELs) Residing  
in Adult Tissues and Their Role in Tissue Rejuvenation and Regeneration 
 
445 
colonies of CD45+CD41+Gr-1–Ter119– cells that, when transplanted into wild-type animals, 
protected them from lethal irradiation and differentiated in vivo into all  major 
hematopoietic lineages (e.g., Gr-1+, B220+ and CD3+ cells) (Ratajczak et al., 2011b). Thus, we 
propose that VSELs are a population of BM-residing PSCs that give rise to long-term- 
engrafting hematopoietic SCs.     
8. Conclusion 
In the past few years, several attempts have been made to purify a population of PSCs from 
adult tissues. We propose that the VSELs described by our team play a physiological role in 
rejuvenation of the pool of TCSCs under steady-state conditions. VSELs developmentally 
originate from epiblast-derived migrating PGCs and they could be deposited in adult 
organs early in development as a reserve pool of primitive SCs for tissue repair and 
regeneration. Therefore, VSELs share several molecular signatures with epiblast and 
migrating PGCs with respect to gene expression and epigenetic programs. Based on the 
developmental origin of VSELs, their proliferation, like PGCs, is controlled by the DNA 
methylation state of some of the developmentally crucial imprinted genes (e.g. H19, Igf2, 
and Rasgrf1). During the ageing process, proliferation-repressive epigenetic marks 
progressively disappear, resulting in the increased sensitivity to Ins/Igf signaling and, 
concomitantly, to depletion of the primitive VSEL population. The decrease in the number 
and pluripotency of these cells will affect pools of TCSCs and have an impact on tissue 
rejuvenation and life span. Furthermore, VSELs can be specified into several tissue-residing 
TCSCs (e.g. MSCs, HSCs, and cardiac SCs) in response to tissue/organ injury. Therefore, 
VSELs isolated from adult tissues are an alternative and ethically uncontroversial source of 
SCs for regenerative medicine. However, to successfully employ VSELs for this purpose, it 
is very important to establish experimental protocols for reprogramming of the growth-
repressive genomic imprinted state of VSELs into the regular somatic pattern to unleash 
their regenerative potential. 
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